ArticleBMC infectious diseases2025
Point-prevalence surveys of hospital-acquired infections in 42 Chinese hospitals in Weifang, China: from 2015 to 2020.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Sustained decline in healthcare-associated infections despite stabilized antimicrobial use: a 10-year study in Southwestern China.Scientific reports · 2026Article
- Fuzzy decision support systems for hospital infection management: a circular q-ROF CRADIS method to prevention and control.Scientific reports · 2026Article
- Prevalence of nosocomial infections and antibiotic resistance patterns in Iranian hospitals over five years.Scientific reports · 2026Article
- Point-prevalence of healthcare-associated infections and antimicrobial use in a tertiary hospital in Shanghai, China: 2012-2023.Antimicrobial resistance and infection control · 2026Observational
- Application of the quality control circle model to reduce non-conforming surgical instrument packaging and hospital-acquired infection risk: a pilot study.Frontiers in cellular and infection microbiology · 2026Article
- Transforming long-term post-acute care for the aging population through home infusion therapy in China: an assessment of need and demand (Part 1).Frontiers in public health · 2026Review
- Mapping the landscape of healthcare-associated infections in China, 2015-2019: a nation-wide observational study.The Lancet regional health. Western Pacific · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital-acquired infections (HAIs) are a major health challenge, especially for developing countries. Therefore, this study investigated the prevalence of HAIs in 42 Chinese hospitals in Weifang, China.
methodsThe definition of HAIs was identified using the Ministry of Health of the People's Republic of China. One-day cross-sectional surveys were annually performed from 2015 to 2020. The trained staff collected information on the prevalence of HAIs, isolated pathogens, and antibiotic use.
resultsAmong the surveyed inpatients, 1.66% developed HAIs, with a significant decline in HAI prevalence from 2015 (1.84%) to 2020 (1.55%) (Z = -4.206, P < 0.001). The ICU exhibited the highest prevalence of HAIs at 19.04%. Lower respiratory tract infections accounted for 46.32% of total cases. Moreover, a total of 1,297 bacterial isolates were identified, with Pseudomonas aeruginosa (218 isolates, 16.8%), Klebsiella pneumoniae (199 isolates, 15.3%), and Escherichia coli (133 isolates, 10.3%) being the most prevalent. The most frequently detected resistant pathogen was Carbapenem-Resistant Enterobacteriaceae(218 isolates,37.20%).Antimicrobial usage reached 35.19%, accompanied by a notable increase in pathogen testing submissions over the study period (Z = 4.287, P < 0.001).
conclusionsThe overall prevalence of HAIs across 42 hospitals shows a declining trend. The prevention and control of healthcare-associated pathogens and multidrug-resistant organisms remain key priorities. Ensuring the rational use of antimicrobial agents is also a critical focus for future efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.